Loteprednol Etabonate
Who holds supplier records for Loteprednol Etabonate? 7 organisations hold a current record for Loteprednol Etabonate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2), India (2), Spain (1) and France (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Loteprednol Etabonate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/loteprednol-etabonate
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Loteprednol Etabonate expires 23 Dec 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Loteprednol Etabonate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Farmabios S.p.A.Italy Company GMP cert on recordActive DMF 27717, 26937 · latest filing Nov 2013
- AARTI PHARMALABS LIMITEDIndiaActive DMF 26249 · latest filing Jul 2012
- CHEMO IBERICA SAActive DMF 38817 · latest filing Mar 2024
- CURIA SPAIN SAUSpain Company GMP cert on recordActive DMF 28031 · latest filing Mar 2014
- INDUSTRIALE CHIMICA SRLItaly Company GMP cert on recordActive DMF 23672 · latest filing Apr 2010
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 32352 · latest filing Feb 2018
- ZACH SYSTEM SAFrance Company GMP cert on recordActive DMF 11105 · latest filing Sept 1994
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Loteprednol Etabonate are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 25435 · filed Dec 2011
- ALP PHARM BEIJING CO LTDInactive DMF 22278 · filed Dec 2008
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (17 listed products contain Loteprednol Etabonate). The latest listed patent expires 23 Dec 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Loteprednol Etabonate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200865).
Chemical identity
- IUPAC name
- chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
- Canonical SMILES
- CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl
- InChIKey
- DMKSVUSAATWOCU-HROMYWEYSA-N
- Synonyms
- Alrex, CDDD 5604, CDDD-5604, CDDD5604, Eysuvis, HGP-1, Inveltys, KPI-121, Lotemax, Lotemax sm, Loteprednol, Loteprednol etabonate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Loteprednol Etabonate?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Loteprednol Etabonate: Farmabios S.p.A. (Italy), AARTI PHARMALABS LIMITED (India), CHEMO IBERICA SA, CURIA SPAIN SAU (Spain), INDUSTRIALE CHIMICA SRL (Italy), Sun Pharmaceutical Industries Limited (India) and ZACH SYSTEM SA (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Loteprednol Etabonate Drug Master Files are active?
Farmabios S.p.A. (DMF 27717, 26937), AARTI PHARMALABS LIMITED (DMF 26249), CHEMO IBERICA SA (DMF 38817), CURIA SPAIN SAU (DMF 28031), INDUSTRIALE CHIMICA SRL (DMF 23672), Sun Pharmaceutical Industries Limited (DMF 32352) and ZACH SYSTEM SA (DMF 11105). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Loteprednol Etabonate records mean?
2 organisations have only inactive Type II DMFs for Loteprednol Etabonate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Loteprednol Etabonate?
Yes. The latest patent listed for an approved US product containing Loteprednol Etabonate expires 23 Dec 2036, across 17 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Loteprednol Etabonate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Loteprednol Etabonate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.